2011 ASH Program Book - American Society of Hypertension

Young Scholar Award*
Monday, May 23, 2011, 1:30 PM – 4:00 PM • East Ballroom • Third Floor
Alessandro Cataliotti, MD, PhD
Alessandro Cataliotti, MD, PhD, is an
associate consultant in the Division of
Cardiovascular Diseases and Internal
Medicine at Mayo Clinic Rochester. He
holds the academic rank of associate
professor of medicine.
Dr. Cataliotti obtained his medical degree
with the highest score cum laude from
the University of Catania, Italy where he
also pursued residency and fellowship
in internal medicine, as well as a PhD
program in cardiovascular science. Dr.
Cataliotti began a research fellowship at
Mayo Clinic under the supervision of Dr. Burnett in 1998. Throughout
his research career, Dr. Cataliotti has been the recipient of numerous
awards, including competitive travel awards from the American Society
of Hypertension in 2000 and 2003; Heart Failure Society of America in
1999, 2000, 2001 and 2003; European Society of Hypertension in 2001;
and International Society of Hypertension in 2002; and many more in
the following years. Of note, Dr. Cataliotti received a two-year grant
from Bristol-Myers Squibb in 1999 in support for his research here at
Mayo Clinic. Dr. Cataliotti was also a recipient of a Beginning Grant in
Aid from the American Heart Association in 2003-2004. From 2005 to
2009, he was awarded a Ministry of Education, University and Research of
Italy (MIUR), Rientro dei Cervelli Project. Underscoring Dr. Cataliotti’s
outstanding research achievements and again recognition by his scientific
peers was the awarding of one of twelve 2006 Doris Duke Clinical Scientist
Development Grants. He has been funded by the National Institutes of
Health and currently is the principal investigator of two RO1s.
Dr. Cataliotti’s research has focused on humoral integration of the heart
and kidney in heart failure and hypertension with a special emphasis
upon the natriuretic peptide system. He has published over 70 publications
in leading peer-reviewed journals, including the Circulation,
Lancet, Proceedings of The National Academy of Science, American
Journal of Physiology, Kidney International, Journal of American Society
of Nephrology, American Journal of Kidney Disease, Peptide, Journal of
Hypertension, Regulatory Peptides, European Journal of Heart Failure,
Hypertension, Circulation Research, American Journal of Hypertension
and the Mayo Clinic Proceedings.
Dr. Cataliotti has been active in the discovery of novel drug delivery
strategies for cardiac peptides in cardiovascular disease and in hypertension.
He was the first to report feasibility of oral delivery of human
B-type natriuretic peptide in experimental hypertension, and has
pioneered the cardiac gene delivery strategy for natriuretic peptides in
hypertensive heart disease.
*Supported by an educational grant from SERVIER.
22